Business Description
Enorama Pharma AB
ISIN : SE0008216329
Compare
Compare
Traded in other countries / regions
ERMA.Sweden IPO Date
2016-06-10Description
Enorama Pharma AB is a pharmaceutical company that focuses on consumer-friendly medicated chewing gum containing generic substances. It provides medicated gums containing generic pharmaceutical substances, developed through its ChewMed technology platform.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.56 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.18 | |||||
| Beneish M-Score | -3.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -19.7 | |||||
| 3-Year EBITDA Growth Rate | 2 | |||||
| 3-Year EPS without NRI Growth Rate | -1.7 | |||||
| 3-Year FCF Growth Rate | 14.9 | |||||
| 3-Year Book Growth Rate | 37.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.55 | |||||
| 9-Day RSI | 32.74 | |||||
| 14-Day RSI | 36.3 | |||||
| 6-1 Month Momentum % | 2.61 | |||||
| 12-1 Month Momentum % | -6.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.16 | |||||
| Quick Ratio | 0.72 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 335.32 | |||||
| Days Sales Outstanding | 831.89 | |||||
| Days Payable | 525.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.1 | |||||
| Shareholder Yield % | -21.1 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -267.08 | |||||
| Operating Margin % | -3680.05 | |||||
| Net Margin % | -3609.52 | |||||
| FCF Margin % | -2693.43 | |||||
| ROE % | -288.53 | |||||
| ROA % | -111.2 | |||||
| ROIC % | -136.83 | |||||
| ROC (Joel Greenblatt) % | -3114.64 | |||||
| ROCE % | -190.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 60.26 | |||||
| PB Ratio | 5.45 | |||||
| EV-to-EBIT | -3.19 | |||||
| EV-to-EBITDA | -3.48 | |||||
| EV-to-Revenue | 111.52 | |||||
| EV-to-FCF | -4.14 | |||||
| Earnings Yield (Greenblatt) % | -31.35 | |||||
| FCF Yield % | -23.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enorama Pharma AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 1.218 | ||
| EPS (TTM) (kr) | -1.956 | ||
| Beta | 0 | ||
| Volatility % | 224.57 | ||
| 14-Day RSI | 36.3 | ||
| 14-Day ATR (kr) | 0.577086 | ||
| 20-Day SMA (kr) | 2.7575 | ||
| 12-1 Month Momentum % | -6.79 | ||
| 52-Week Range (kr) | 1.680808 - 8.484848 | ||
| Shares Outstanding (Mil) | 60.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enorama Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enorama Pharma AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enorama Pharma AB Frequently Asked Questions
What is Enorama Pharma AB(OSTO:ERMA)'s stock price today?
The current price of OSTO:ERMA is kr2.35. The 52 week high of OSTO:ERMA is kr8.48 and 52 week low is kr1.68.
When is next earnings date of Enorama Pharma AB(OSTO:ERMA)?
The next earnings date of Enorama Pharma AB(OSTO:ERMA) is 2024-05-22.
Does Enorama Pharma AB(OSTO:ERMA) pay dividends? If so, how much?
Enorama Pharma AB(OSTO:ERMA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers